Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Healthcare
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:RVV)

This life sciences company is gearing up to treat long COVID

Jocelyn Aspa April 25, 2024

Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID

GlobeNewswire April 23, 2024

Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product

GlobeNewswire April 18, 2024

Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder

GlobeNewswire April 2, 2024

Revive Therapeutics Submits Type C Meeting Request Package to FDA for Clinical Study of Bucillamine to Treat Long COVID

GlobeNewswire March 27, 2024

Revive Therapeutics To Submit Type C Meeting Request with FDA for Bucillamine to Treat Long COVID

GlobeNewswire March 19, 2024

Revive Therapeutics Provides Corporate Update

GlobeNewswire March 12, 2024

Revive Therapeutics Ltd. Announces Closing of the Second and Final Tranche of Its Private Placement for Gross Proceeds of $1,187,110

GlobeNewswire February 26, 2024

Revive Therapeutics Explores the Use of Bucillamine for Long COVID

GlobeNewswire February 1, 2024
View More News ››

Opinion & Analysis (CSE:RVV)

A Potential Psychedelic and COVID Therapy Play…All in One Stock

Dave Jackson June 18, 2020

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19

Streetwise Reports June 4, 2020
View More Opinion ››

Bullboard Posts (CSE:RVV)

Next week's live was canceled per ftmig Twitter

Rvv posted on their handle for X that they will schedule something soon on a different platform.  
adoubleyou - May 3, 2024

Rescheduled - Wednesday May 8th at 2pm ET.

https://twitter.com/FTMInvest/status/1786167849834127412  
cool888 - May 2, 2024

Mike frank to go live Wednesday may 8th at 7pm et

Apologies for our failed x space earlier with Revive_RVV  RVV CEO Michael Frank. For all that were tuned in we hope you weren'...
adoubleyou - May 2, 2024

RE:An Overview & Q&A with CEO Michael Frank May 2nd 4pm

Is the 4 PM EDT Q&A strictly for X subscribers? G1945V
G1945V - May 2, 2024

An Overview & Q&A with CEO Michael Frank May 2nd 4pm

Link - https://twitter.com/ftminvest/status/1784693118308122941?s=46&t=LsRlg0oC9EbPON1oBKpUbw
Tesla888 - April 29, 2024

$RVV - FDA mtg June 7th

https://ca.finance.yahoo.com/news/revive-therapeutics-announces-fda-acceptance-110000050.html
Tesla888 - April 18, 2024
View more Bullboard ››

Hillcrest Energy Technologies Ltd.

Hillcrest Energy Technologies Ltd.

Hillcrest Energy Technologies is a clean tech innovation company developing high value, high-performance control systems and ...
View More »